Shaun Scott, MD
Otolaryngology · Charleston, SCNPI 1932106747
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $127 and has fallen 55.8% since, to $56 in 2025. That places this record below the midpoint for otolaryngology clinicians in SC, where the typical reported total is $1,243.
Across 17 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$75
- Intersect ENT, Inc.$68
- Stryker$41
- Regeneron Healthcare Solutions, Inc.$35
- Medtronic$33
- Genentech USA, Inc.$30
- plus $88 from 5 others
Across 7 payments — averaging $4680.00 each. An ownership or investment interest held by the physician or an immediate family member.
- The North Carolina Mutual Wholesale Drug Company Inc$33K
What the payments were for
- Food & beverage$369100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 5 | $75 |
| Intersect ENT, Inc. | 2 | $68 |
| Stryker | 1 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Medtronic(2 entities) | 2 | $33 |
| Genentech USA, Inc. | 1 | $30 |
| Sanofi | 1 | $25 |
| Alk-abello, Inc | 1 | $22 |
| GSK | 1 | $16 |
| Merck | 1 | $14 |
| AstraZeneca | 1 | $11 |
How this compares
$369 in reported general payments places this provider in the 20th percentile of 180 otolaryngology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 86 | $1,763 |
| Montelukast Sodium | 195 | $1,689 |
| Epinephrine | 12 | $1,365 |
| Levocetirizine Dihydrochloride | 105 | $1,328 |
| Ipratropium Bromide | 39 | $1,210 |
| Fluticasone Propionate | 66 | $778 |
| Cefdinir | 32 | $533 |
| Methylprednisolone | 79 | $475 |
| Mometasone Furoate | 30 | $245 |
| Omeprazole | 14 | $153 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $100 |
| Prednisone | 64 | $99 |
| Mupirocin | 13 | $95 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Charleston
- Shaun NguyenCharleston$973K
- Rodney SchlosserCharleston$382K
- Zachary SolerCharleston$67K
- Eugene BrownCharleston$28K
- Jason NewmanCharleston$26K
- Joshua HornigCharleston$25K
- Ashli OrourkeCharleston$21K
- Alexandra KejnerCharleston$19K
- Evan GraboyesCharleston$18K
- Mohamed AbdelwahabCharleston$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.